ArticleFrontiers in neurology2025
Development of a machine learning model for prognostic prediction of severe sudden sensorineural hearing loss with hyperbaric oxygen therapy.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Severe sudden sensorineural hearing loss (SSNHL) has heterogeneous causes and variable outcomes, making individualized prognosis difficult. We aimed to develop and evaluate a machine-learning (ML) model to predict recovery in severe SSNHL while treating hyperbaric oxygen therapy (HBOT) as an exposure feature rather than inferring causal treatment effects. Methods: In a single-center retrospective cohort, we analyzed clinical and audiometric data from 231 in patients with severe SSNHL treated between January 2015 and January 2024. Recovery was defined by Siegel's criteria; eligibility required ≥70 dB loss and treatment initiation within 1 month of onset. Candidate predictors included demographics, comorbidities, baseline thresholds, time to treatment, and HBOT variables (e.g., session count). We trained a custom multilayer perceptron with 12 input features and compared it with conventional algorithms. Performance was assessed using accuracy, F1 score, precision, recall, and area under the ROC curve (AUC). Results: Among 231 patients, the custom model achieved 89.36% test accuracy and an AUC of 0.8716, outperforming several conventional methods. Key predictors included age, diabetes, dizziness, and HBOT exposure. Notably, "≥10 HBOT sessions" showed high importance in logistic regression and SVM models, suggesting prognostic relevance of sufficient cumulative HBOT exposure. Conclusion: Including HBOT information as a feature improved prediction of recovery in severe SSNHL; however, these findings do not establish the therapeutic efficacy of HBOT. The model may support clinician-patient decision-making by providing individualized recovery probabilities. Limitations include the retrospective single-center design, modest sample size, and class imbalance, underscoring the need for external validation and better adjustment for confounding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.